INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Suven Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543064	ISIN Demat INE03QK01018	Book Value 86.66	NSE Symbol SUVENPHAR	Dividend Yield (%) 0	Market Cap (₹ Cr.) 29,729.37	P/E 105.69	EPS 11.05	Face Value 1

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	1,024.99	1,330.08	1,320.22	1,009.72	833.79
Sale of Products	974.21	1,283.85	1,253.37	949.33	773.57
Sale of Services	35.28	37.01	53.64	46.13	43.71
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	15.51	9.22	13.21	14.25	16.51
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	1,024.99	1,330.08	1,320.22	1,009.72	833.79
Other Income	55.09	44.55	187.79	14.24	18.12
Total Revenue	1,080.09	1,374.63	1,508.01	1,023.96	851.91
Changes in Inventories	53.88	-20.94	-60.35	-8.37	-11.05
Cost of Material Consumed	248.38	421.36	459.46	310.32	240.24
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	0.00	0.00	0.00	0.00	0.00
Employee Benefits	126.88	108.58	100.48	76.23	65.10
Total Other Expenses	185.95	230.39	240.65	191.02	157.85
Manufacturing / Operating Expenses	127.78	171.65	173.19	133.79	103.84
Administrative and Selling Expenses	40.43	45.24	53.99	46.10	45.60
Other Expenses	17.75	13.50	13.46	11.13	8.41
Finance Costs	7.43	12.75	6.23	9.14	18.66
Depreciation and Amortization	48.79	43.10	39.10	31.64	23.51
Total Expenses	671.31	795.24	785.56	609.98	494.32
Profit Before Exceptional Items and Tax	408.77	579.39	722.45	413.98	357.59
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	408.77	579.39	722.45	413.98	357.59
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	408.77	579.39	722.45	413.98	357.59
Taxation	103.96	146.79	164.35	105.33	87.51
Current Tax	98.14	144.63	157.63	101.54	88.81
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	6.59	4.34	6.72	3.62	-1.30
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	-0.78	-2.17	0.00	0.18	0.00
Profit After Tax	304.82	432.60	558.10	308.65	270.08
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	304.82	432.60	558.10	308.65	270.08
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	304.82	432.60	558.10	308.65	270.08
Earning Per Share - Basic	11.97	16.99	21.92	12.12	10.61
Earning Per Share - Diluted	11.97	16.99	21.92	12.12	10.61
Operation Profit before Depreciation	464.99	635.24	767.78	454.76	399.76
Operating Profit after Depreciation	416.20	592.14	728.68	423.12	376.25
Dividend Per Share	0.00	6.00	5.00	2.00	5.00
Dividend Percentage	0.00	600.00	500.00	200.00	500.00
Equity Dividend	0.00	152.74	127.28	50.91	63.64
Weighted Average Shares - Basic	25.46	25.46	25.46	25.46	25.46
Weighted Average Shares - Diluted	25.46	25.46	25.46	25.46	25.46